Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination


Novartis today announced a voluntary recall of three lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level. The oral suspension lots are being recalled because of a risk of potential peanut flour contamination that occurred at a third-party contract manufacturing site. (US Food Recalls) More More

Similar stories

Medication for Thrombocytopenia, Aplastic Anemia Recalled Due to Potential Peanut Contamination - Pharmacy Times

Medication for Thrombocytopenia, Aplastic Anemia Recalled Due to Potential Peanut Contamination  Pharmacy Times

Posted on 13 May 2019 | 2:00 am | Google News

Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination - FDA.gov

Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination  FDA.gov

Posted on 11 May 2019 | 2:00 am | Google News

Copyright © 2019 LastMinuteStuff.com | Contact info